✦ LIBER ✦

Population pharmacodynamics (PD) of cabergoline (CAB), in patients with parkinson's disease.

✍ Scribed by Fullerton, T.; Forrest, A.; Collins, D.A.; Narang, P.K.

Book ID: 110019631
Publisher: Nature Publishing Group
Year: 1996
Tongue: English
Weight: 121 KB
Volume: 59
Category: Article
ISSN: 0009-9236
DOI: 10.1038/sj.clpt.1996.206

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PK-PD-Relationship of Apomorphine in Pat

PK-PD-Relationship of Apomorphine in Patients with Parkinson's Disease

✍ Harder, S.; Baas, H.; Röger, S.; Demisch, L. 📂 Article 📅 1996 🏛 Nature Publishing Group 🌐 English ⚖ 116 KB

Bedtime cabergoline in Parkinson’s disea

Bedtime cabergoline in Parkinson’s disease patients with excessive daytime sleepiness induced by dopamine agonists

✍ P. Dotto; G. Gambaccini; D. Caneparo; C. Berti; S. Bernardini; U. Bonuccelli 📂 Article 📅 2003 🏛 Springer Milan 🌐 English ⚖ 58 KB

Usefulness of switching to cabergoline f

Usefulness of switching to cabergoline from other dopamine agonists in patients with advanced Parkinson’s disease

✍ M. Shiraishi; T. Kamo; M. Hotta; S. Nemoto; J. Oshima; H. Sugihara; S. Yasaki; M 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 106 KB

Sleep-wake cycle and effects of cabergol

Sleep-wake cycle and effects of cabergoline monotherapy in de novo Parkinson’s disease patients

✍ F. Placidi; F. Izzi; A. Romigi; P. Stanzione; M. G. Marciani; L. Brusa; F. Sperl 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 203 KB

Development of Parkinson's disease in pa

Development of Parkinson's disease in patients with blepharospasm

✍ Federico Micheli; María Clara Scorticati; Silvia Folgar; Emilia Gatto 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Genetic polymorphism of catechol-O-methy

Genetic polymorphism of catechol-O-methyltransferase and levodopa pharmacokinetic–pharmacodynamic pattern in patients with Parkinson's disease

✍ Manuela Contin; Paolo Martinelli; Mirella Mochi; Roberto Riva; Fiorenzo Albani; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

## Abstract We explored the potential effect of catechol‐__O__‐methyltransferase (COMT) genetic polymorphism on the pharmacokinetics and pharmacodynamics of a standard oral dose of levodopa in patients with Parkinson's disease (PD). We prospectively collected blood samples for COMT genotyping from